• Finally, a Winner for Alzheimer's? Antiamyloid Shows Promise

    2 monthes ago - By Medscape

    A phase 2 study shows that a high dose of an experimental antiamyloid agent reduced amyloid burden as well as cognitive and functional decline.
    Medscape Medical News
    Read more ...

     

  • Experts describe role of quantitative systems pharmacology in first-in-human clinical trials

    2 monthes ago - By News Medical

    Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its "Letter to the Editor" describing the important role that quantitative systems pharmacology can play in defining dosing criteria for first-in-human clinical trials, together with the European Medicines Agency's response.
    Read more ...

     

  • Alzheimer's Drug From Biogen And Eisai Shows Some Promise Of Delaying Disease

    2 monthes ago - By CommonHealth Wbur

    There's some promising news when it comes to treating Alzheimer's. Cambridge-based Biogen and its Japanese partner Eisai announced results from a highly-anticipated study on a drug called BAN2401.
    Read more ...

     

  • Promising Alzheimer drug reduces plaques in brains and slows dementia, a first for a large clinical trial

    Promising Alzheimer drug reduces plaques in brains and slows dementia, a first for a large clinical trial

    2 monthes ago - By National Post

    The long-elusive quest for a medication that works to treat Alzheimer's reached a potentially promising milestone Wednesday. For the first time in a large clinical trial, a drug was able to both reduce the plaques in the brains of patients and slow the progression of dementia.
    More extensive trials will be needed to know if the drug is truly effective, but if the results, presented Wednesday at the Alzheimer's Association International Conference in Chicago, are borne out, the drug may be the first to successfully attack both the brain changes and the symptoms of Alzheimer's.
    “This trial...
    Read more ...